157 related articles for article (PubMed ID: 9160262)
1. Whole blood cyclosporin monitoring in liver and heart transplant patients: evaluation of the specificity of a fluorescence polarization immunoassay and an enzyme-multiplied immunoassay technique.
Gulbis B; Van der Heijden J; van As H; Thiry P
J Pharm Biomed Anal; 1997 Apr; 15(7):957-63. PubMed ID: 9160262
[TBL] [Abstract][Full Text] [Related]
2. A comparison of EMIT and FPIA methods for the detection of cyclosporin A blood levels: does impaired liver function make a difference?
Witzke O; Heemann U; Thesing A; Wolfhard U; Erhard J; Philipp T; Michel MC
Eur J Clin Pharmacol; 1997; 52(5):413-6. PubMed ID: 9272414
[TBL] [Abstract][Full Text] [Related]
3. The EMIT Cyclosporine Assay: development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers.
Dias VC; Legatt DF; Yatscoff RW
Clin Biochem; 1997 Mar; 30(2):155-62. PubMed ID: 9127698
[TBL] [Abstract][Full Text] [Related]
4. Comparison of high-performance liquid chromatography and monoclonal fluorescence polarization immunoassay for the determination of whole-blood cyclosporin A in liver and heart transplant patients.
Taylor PJ; Salm P; Norris RL; Ravenscroft PJ; Pond SM
Ther Drug Monit; 1994 Oct; 16(5):526-30. PubMed ID: 7846754
[TBL] [Abstract][Full Text] [Related]
5. [Heart and liver graft: therapeutic monitoring of cyclosporine by two techniques, mFPIA and EMIT].
Gulbis B; Van der Heijden J; As HV; Thiry P
Therapie; 1997; 52(4):327-8. PubMed ID: 9437886
[No Abstract] [Full Text] [Related]
6. Analytical performance of the CEDIA cyclosporine PLUS whole blood immunoassay.
Butch AW; Fukuchi AM
J Anal Toxicol; 2004 Apr; 28(3):204-10. PubMed ID: 15107152
[TBL] [Abstract][Full Text] [Related]
7. Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients.
McBride JH; Kim SS; Rodgerson DO; Reyes AF; Ota MK
Clin Chem; 1992 Nov; 38(11):2300-6. PubMed ID: 1424128
[TBL] [Abstract][Full Text] [Related]
8. Considerable lack of agreement between S-FPIA and EMIT cyclosporine assay in therapeutic drug monitoring, of heart transplant recipients.
Regazzi MB; Molinaro M; Tinelli C; D'Eril GM; Goggi C; Campana C; Fiorito V; Moratti R; Viganò M
Ther Drug Monit; 2000 Dec; 22(6):712-5. PubMed ID: 11128239
[TBL] [Abstract][Full Text] [Related]
9. Progress report of an external quality assessment scheme for cyclosporine assay.
Zucchelli GC; Pilo A; Chiesa MR; Scarlattini M; Bizollon CA
Ther Drug Monit; 1996 Jun; 18(3):273-9. PubMed ID: 8738767
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC.
Schütz E; Svinarov D; Shipkova M; Niedmann PD; Armstrong VW; Wieland E; Oellerich M
Clin Chem; 1998 Oct; 44(10):2158-64. PubMed ID: 9761250
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cyclosporine measurement in whole blood by high-performance liquid chromatography, monoclonal fluorescence polarization immunoassay, and monoclonal enzyme-multiplied immunoassay.
Dusci LJ; Hackett LP; Chiswell GM; Ilett KF
Ther Drug Monit; 1992 Aug; 14(4):327-32. PubMed ID: 1519308
[TBL] [Abstract][Full Text] [Related]
12. The specificity of monoclonal fluorescence polarization immunoassay for cyclosporine in recipients of simultaneous pancreas-kidney transplants.
Kaplan B; Wang Z; Keilani T; Kaufman DB
Ther Drug Monit; 1995 Oct; 17(5):499-503. PubMed ID: 8585113
[TBL] [Abstract][Full Text] [Related]
13. FPIA and EMIT methods compared for cyclosporine monitoring in heart transplant patients.
Fatio R; Sütsch G; Pei P; Follath F; Kiowski W
Clin Chem; 1998 Mar; 44(3):693-4. PubMed ID: 9510894
[No Abstract] [Full Text] [Related]
14. Conversion of cardiac and liver transplant recipients from HPLC and FPIA (polyclonal) to an FPIA (monoclonal) technique for measurement of blood cyclosporin A.
McBride JH; Kim S; Rodgerson DO; Reyes A
J Clin Lab Anal; 1998; 12(6):337-42. PubMed ID: 9850184
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of instrumental, nonisotopic immunoassays (fluorescence polarization immunoassay and enzyme-multiplied immunoassay technique) for cyclosporine monitoring in whole blood after kidney and liver transplantation.
Beutler D; Molteni S; Zeugin T; Thormann W
Ther Drug Monit; 1992 Oct; 14(5):424-32. PubMed ID: 1448852
[TBL] [Abstract][Full Text] [Related]
16. A comparison of cyclosporine assays using sequential samples from selected transplant patients.
LeGatt DF; Coates JE; Simpson AI; Shalapay CE; Rintoul BJ; Yatscoff RW
Clin Biochem; 1994 Feb; 27(1):43-8. PubMed ID: 8200114
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal fluorescence polarization immunoassay evaluated for monitoring cyclosporine in whole blood after kidney, heart, and liver transplantation.
Winkler M; Schumann G; Petersen D; Oellerich M; Wonigeit K
Clin Chem; 1992 Jan; 38(1):123-6. PubMed ID: 1733584
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the New Cyclosporine and Tacrolimus Automated Electrochemiluminescence Immunoassays under Field Conditions.
Toole B; Gechtman C; Dreier J; Kuhn J; Gutierrez MR; Barrett A; Niederau C
Clin Lab; 2015; 61(9):1303-15. PubMed ID: 26554251
[TBL] [Abstract][Full Text] [Related]
19. Monitoring cyclosporin A (ciclosporin, INN) concentrations in whole blood: evaluation of the EMIT assay in comparison with HPLC and RIA.
Schumann G; Petersen D; Hoyer PF; Wonigeit K
Eur J Clin Chem Clin Biochem; 1993 Jun; 31(6):381-8. PubMed ID: 8369366
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin assay performance in patients with acute renal failure.
Trujillo TN; Sowinski KM; Venezia RA; Scott MK; Mueller BA
Intensive Care Med; 1999 Nov; 25(11):1291-6. PubMed ID: 10654216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
